前往化源商城

Neurokinin Receptor (393-407), rat

更新时间:2024-09-17 12:08:02

Neurokinin Receptor (393-407), rat结构式
Neurokinin Receptor (393-407), rat结构式
品牌特惠专场
常用名 Neurokinin Receptor (393-407), rat 英文名 Neurokinin Receptor (393-407), rat
CAS号 153607-26-2 分子量 1696.90
密度 N/A 沸点 N/A
分子式 C72H113N17O26S2 熔点 N/A
MSDS N/A 闪点 N/A

 Neurokinin Receptor (393-407), rat用途


神经激肽受体(393-407),大鼠(SPR393–407)是一种大鼠神经激肽1受体(NK1R)片段。NK1R通过内吞作用迅速内化,并在与P物质(SP)结合时循环至质膜。神经激肽受体(393-407),大鼠可用于神经源性炎症的研究[1][2]。

 Neurokinin Receptor (393-407), rat名称

英文名 Neurokinin Receptor (393-407), rat

 Neurokinin Receptor (393-407), rat生物活性

描述 神经激肽受体(393-407),大鼠(SPR393–407)是一种大鼠神经激肽1受体(NK1R)片段。NK1R通过内吞作用迅速内化,并在与P物质(SP)结合时循环至质膜。神经激肽受体(393-407),大鼠可用于神经源性炎症的研究[1][2]。
相关类别
靶点

NK1

体外研究 神经激肽受体(393-407),大鼠(10pM)抑制 50% 的 125I-SPR393-407与抗血清结合。
参考文献

[1]. Nathan JD, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2001 Nov;281(5):G1322-8.  

[2]. Vigna SR, et al. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells. J Neurosci. 1994 Feb;14(2):834-45.  

 Neurokinin Receptor (393-407), rat物理化学性质

分子式 C72H113N17O26S2
分子量 1696.90
品牌现货直购
推荐供应商:

暂无推荐供应商。我要出现这里

相关化合物: 更多...
Neurokinin-1 Receptor Antagonist
337505-63-2
neurokinin B (4-10), beta-Asp(4)-Me-Phe(7)-
114317-52-1
Neurokinin B trifluoroacetate salt
86933-75-7
neurokinin B, Pro(2)-Trp(6,8)-Nle(10)-
105869-12-3
Neurokinin A trifluoroacetate salt
86933-74-6
Neurokinin A(4-10)
97559-35-8
Neurokinin antagonist 1
214487-45-3
neurokinin A-OH
102989-34-4
neurokinin A (4-10), Tyr(5)-Trp(6,8,9)-Arg(10)-
126050-12-2
5,5-Dimethylpiperidin-2-imine hydrochloride
179684-15-2
(2S,3R,4S,5S)-2-[[(3S,4S,4aR,6aR,6bS,8aR,9R,12aS,14aR,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]oxane-3,4,5-triol
170663-67-9
(2S,3R,4S,5S,6R)-2-[[(2R,3S)-3,7-dihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3,4-dihydro-2H-chromen-5-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
105330-54-9
(2S,3R,4S,5S,6R)-2-[[(2R,3S)-3,5-dihydroxy-2-[4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3,4-dihydro-2H-chromen-7-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
105330-53-8
(2R,3S)-2-[3,4-bis[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]phenyl]-3,4-dihydro-2H-chromene-3,5,7-triol
105330-55-0
(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl I(2)-D-glucopyranoside
103303-00-0
(+)-Catechin-6-C-I(2)-D-glucopyranoside
105371-27-5
(1S)-1,5-Anhydro-1-C-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-8-yl]-D-glucitol
105371-26-4
(2R,3R)-2-(3,4-dihydroxyphenyl)-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-chromene-3,5,7-triol
103215-49-2
(2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-chromene-3,5,7-triol
103215-48-1